Rudlowski C - Search Results

1

Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFbetaR therapy.

Classen S, Muth C, Debey-Pascher S, Eggle D, Beyer M, Mallmann MR, Rudlowski C, Zander T, Pölcher M, Kuhn W, Lahn M, Schultze JL, Staratschek-Jox A. Classen S, et al. Among authors: rudlowski c. Pharmacogenet Genomics. 2010 Mar;20(3):147-56. doi: 10.1097/FPC.0b013e328335731c. Pharmacogenet Genomics. 2010. PMID: 20084050

2

Influence of preoperative MRI on the surgical management of patients with operable breast cancer.

Braun M, Pölcher M, Schrading S, Zivanovic O, Kowalski T, Flucke U, Leutner C, Park-Simon TW, Rudlowski C, Kuhn W, Kuhl CK. Braun M, et al. Among authors: rudlowski c. Breast Cancer Res Treat. 2008 Sep;111(1):179-87. doi: 10.1007/s10549-007-9767-5. Epub 2007 Sep 29. Breast Cancer Res Treat. 2008. PMID: 17906928

3

Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer--a prospective multicenter phase II trial (PRIMOVAR).

Pölcher M, Mahner S, Ortmann O, Hilfrich J, Diedrich K, Breitbach GP, Höss C, Leutner C, Braun M, Möbus V, Karbe I, Stimmler P, Rudlowski C, Schwarz J, Kuhn W. Pölcher M, et al. Among authors: rudlowski c. Oncol Rep. 2009 Sep;22(3):605-13. doi: 10.3892/or_00000479. Oncol Rep. 2009. PMID: 19639211 Clinical Trial.

4

Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.

Braun M, Wardelmann E, Debald M, Walgenbach-Bruenagel G, Höller T, Wolfgarten M, Sauerwald A, Rudlowski C, Büttner R, Kuhn W, Pölcher M. Braun M, et al. Among authors: rudlowski c. Onkologie. 2009 Dec;32(12):732-8. doi: 10.1159/000252795. Epub 2009 Nov 20. Onkologie. 2009. PMID: 20016234

5

Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma.

Pölcher M, Braun M, Friedrichs N, Rudlowski C, Bercht E, Fimmers R, Sauerwald A, Keyver-Paik MD, Kübler K, Büttner R, Kuhn WC, Hernando JJ. Pölcher M, et al. Among authors: rudlowski c. Cancer Immunol Immunother. 2010 Jun;59(6):909-19. doi: 10.1007/s00262-010-0817-1. Epub 2010 Jan 20. Cancer Immunol Immunother. 2010. PMID: 20087581 Free PMC article. Clinical Trial.

6

Increased detection of lymphatic vessel invasion by D2-40 (podoplanin) in early breast cancer: possible influence on patient selection for accelerated partial breast irradiation.

Debald M, Pölcher M, Flucke U, Walgenbach-Brünagel G, Walgenbach KJ, Höller T, Wolfgarten M, Rudlowski C, Büttner R, Schild H, Kuhn W, Braun M. Debald M, et al. Among authors: rudlowski c. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1128-33. doi: 10.1016/j.ijrobp.2009.06.088. Epub 2010 Feb 3. Int J Radiat Oncol Biol Phys. 2010. PMID: 20133078

7

Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Pölcher M, Eckhardt M, Coch C, Wolfgarten M, Kübler K, Hartmann G, Kuhn W, Rudlowski C. Pölcher M, et al. Among authors: rudlowski c. Cancer Chemother Pharmacol. 2010 May;66(1):203-7. doi: 10.1007/s00280-010-1276-2. Epub 2010 Mar 5. Cancer Chemother Pharmacol. 2010. PMID: 20204367 Free article. Clinical Trial.

8

In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer.

Pölcher M, Rudlowski C, Friedrichs N, Mielich M, Höller T, Wolfgarten M, Kübler K, Büttner R, Kuhn W, Braun M. Pölcher M, et al. Among authors: rudlowski c. BMC Cancer. 2010 Apr 13;10:137. doi: 10.1186/1471-2407-10-137. BMC Cancer. 2010. PMID: 20388201 Free PMC article. Clinical Trial.

9

Changes in Ki-67 labeling indices during neoadjuvant chemotherapy for advanced ovarian cancer are associated with survival.

Pölcher M, Friedrichs N, Rudlowski C, Fimmers R, Keyver-Paik MD, Kübler K, Sauerwald A, Büttner R, Kuhn W, Braun M. Pölcher M, et al. Among authors: rudlowski c. Int J Gynecol Cancer. 2010 May;20(4):555-60. doi: 10.1111/IGC.0b013e3181c104c0. Int J Gynecol Cancer. 2010. PMID: 20442588

10

Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells.

Kübler K, Gehrke N, Riemann S, Böhnert V, Zillinger T, Hartmann E, Pölcher M, Rudlowski C, Kuhn W, Hartmann G, Barchet W. Kübler K, et al. Among authors: rudlowski c. Cancer Res. 2010 Jul 1;70(13):5293-304. doi: 10.1158/0008-5472.CAN-10-0825. Epub 2010 Jun 15. Cancer Res. 2010. PMID: 20551064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters